Vahaticor, Inc.

This early study is testing a small, self-expanding device called the A-FLUX Reducer that gets implanted in a heart vein. It aims to reduce chest pain and improve symptoms in people with coronary microvascular dysfunction—a condition where tiny heart vessels don't work properly—w…